The problems and promises of research into human immunology and autoimmune disease, Nature Medicine, vol.476, issue.1, pp.18-48, 2012. ,
DOI : 10.1056/NEJMra020100
Translational Mini-Review Series on Type 1 Diabetes:???Systematic analysis of T cell epitopes in autoimmune diabetes, Clinical & Experimental Immunology, vol.406, issue.Suppl. 2, pp.148-149, 2007. ,
DOI : 10.1111/j.1365-2249.2006.03244.x
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes, Proceedings of the National Academy of Sciences, vol.104, issue.43, pp.17040-17045, 2007. ,
DOI : 10.1073/pnas.0705894104
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8 (+) T cell epitope in HLA-A2 (+) type 1 diabetic patients, Diabetologia, pp.55-2026, 2012. ,
T-cell responses to autoantigens in IDDM. The search for the Holy Grail, Diabetes, pp.45-1147, 1996. ,
Proposed guidelines on screening for risk of type 1 diabetes, Diabetes Care, pp.24-398, 2001. ,
Immune biomarkers in immunotherapeutic trials for type 1 diabetes: Cui prodest?, Diabetes & Metabolism, vol.38, issue.5, pp.379-385, 2012. ,
DOI : 10.1016/j.diabet.2012.05.005
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients, J. Exp. Med, vol.209, pp.51-60, 2012. ,
An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes, Diabetes, pp.59-759, 2009. ,
Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus, JAMA, pp.297-1568, 2007. ,
To B or Not to B: (Anti)bodies of Evidence on the Crime Scene of Type 1 Diabetes?, Diabetes, vol.60, issue.8 ,
DOI : 10.2337/db11-0700
Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial, Lancet, pp.378-487, 2011. ,
Anti-CD3 antibodies for type 1 diabetes: beyond expectations, The Lancet, vol.378, issue.9790, pp.378-459, 2011. ,
DOI : 10.1016/S0140-6736(11)60980-X
Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients, Proc. Natl. Acad. Sci. U.S.A, vol.102, pp.10581-10586, 2005. ,
CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes, Diabetes, pp.56-613, 2007. ,
Cells Specific for Different Islet Cell-Associated Epitopes Using Combinatorial MHC Multimers, Diabetes, pp.59-1721, 2010. ,
HLA-B7-Restricted Islet Epitopes Are Differentially Recognized in Type 1 Diabetic Children and Adults and Form Weak Peptide-HLA Complexes, Diabetes, pp.61-2546, 2012. ,
Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes, Proc. Natl. Acad. Sci. U.S.A, vol.102, pp.18425-18430, 2005. ,
Equivalent Specificity of Peripheral Blood and Islet-Infiltrating CD8+ T Lymphocytes in Spontaneously Diabetic HLA-A2 Transgenic NOD Mice, The Journal of Immunology, vol.180, issue.8, pp.180-5430, 2008. ,
DOI : 10.4049/jimmunol.180.8.5430
Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death, Diabetes, pp.60-2112, 2011. ,
Single Insulin-Specific CD8+ T Cells Show Characteristic Gene Expression Profiles in Human Type 1 ,
URL : https://hal.archives-ouvertes.fr/hal-00645775
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope, J. Clin. Invest, vol.118, pp.3390-3402, 2008. ,
Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice, Diabetologia, vol.48, issue.1, pp.48-75, 2005. ,
DOI : 10.1007/s00125-004-1613-2
In Vivo Cytotoxicity of Insulin-Specific CD8+ T-Cells in HLA-A*0201 Transgenic NOD Mice, Diabetes, vol.56, issue.10, pp.56-2551, 2007. ,
DOI : 10.2337/db07-0332
Islet-Specific CTL Cloned from a Type 1 Diabetes Patient Cause Beta-Cell Destruction after Engraftment into HLA-A2 Transgenic NOD, PLoS One, vol.7, p.49213, 2012. ,
The Frequency and Immunodominance of Islet-Specific CD8+ T-cell Responses Change after Type 1 Diabetes Diagnosis and Treatment, Diabetes, vol.57, issue.5, pp.57-1312, 2008. ,
DOI : 10.2337/db07-1594
URL : https://hal.archives-ouvertes.fr/inserm-00266516
Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group, J. Clin. Invest, vol.101, pp.327-336, 1998. ,
Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus, PLoS ONE, vol.51, issue.1 ,
DOI : 10.1371/journal.pone.0001374.s001
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes, Diabetes Care, pp.31-1966, 2008. ,
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes, Nature Reviews Immunology, vol.27, issue.2, pp.145-152, 2010. ,
DOI : 10.1038/nri2705
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes, N. Engl. J. Med, pp.352-2598, 2005. ,
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function ,
Rituximab Selectively Suppresses Specific Islet Antibodies, Diabetes, vol.60, issue.10, pp.60-2560, 2011. ,
DOI : 10.2337/db11-0674
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178300
GAD treatment and insulin secretion in recent-onset type 1 diabetes, N. Engl. J. Med, p.359, 1909. ,
Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes, PLoS One, vol.6, p.29008, 2011. ,
GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65, Diabetes, vol.49, issue.10, pp.49-1621, 2000. ,
DOI : 10.2337/diabetes.49.10.1621
Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes, Diabetes Care, vol.27, pp.2348-2355, 2004. ,
Beyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes, Endocrine Reviews, vol.32, issue.5, pp.32-623, 2011. ,
DOI : 10.1210/er.2011-0010
Short-term subcutaneous insulin treatment delays but does not prevent diabetes in NOD mice, European Journal of Immunology, vol.339, issue.Suppl 1, pp.42-1553, 2012. ,
DOI : 10.1002/eji.201242394
Davis, T cell assays and MIATA: the essential minimum for maximum impact, Immunity, pp.37-38, 2012. ,
Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society, Clin. Exp. Immunol, pp.163-196, 2011. ,
Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive ,
Autoreactive T cell Responses in Insulin-dependent (Type 1) Diabetes Mellitus. Report of the First International Workshop for Standardization of T cell assays, Journal of Autoimmunity, vol.13, issue.2, pp.13-267, 1999. ,
DOI : 10.1006/jaut.1999.0312
Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes ,
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand, Nat. Med, vol.6, pp.1167-1175, 2000. ,
A Prescription for Human Immunology, Immunity, vol.29, issue.6, pp.29-835, 2008. ,
DOI : 10.1016/j.immuni.2008.12.003
Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?, Clinical and Developmental Immunology, vol.65, issue.8, p.2011, 2011. ,
DOI : 10.1007/s11892-008-0017-y
Evidence That Nasal Insulin Induces Immune Tolerance to Insulin in Adults With Autoimmune Diabetes, Diabetes, vol.60, issue.4, pp.60-1237, 2011. ,
DOI : 10.2337/db10-1360
Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes ,
Current Advances and Travails in Islet Transplantation, Diabetes, vol.58, issue.10, pp.58-2175, 2009. ,
DOI : 10.2337/db09-0476
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients, Diabetes, vol.48, issue.3, pp.48-484, 1999. ,
DOI : 10.2337/diabetes.48.3.484
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation, PLoS One, vol.3, p.2435, 2008. ,
Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients, Diabetes, pp.58-2267, 2009. ,
Allograft-Specific Cytokine Profiles Associate with Clinical Outcome After Islet Cell Transplantation, American Journal of Transplantation, vol.178, issue.2, pp.382-388, 2009. ,
DOI : 10.1111/j.1600-6143.2008.02479.x
Tolerance to kidney allograft transplanted into Type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches, Diabetologia, pp.42-1379, 1999. ,
Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients, Transplantation, pp.80-118, 2005. ,
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation, Am. J. Transplant, vol.7, pp.1242-1248, 2007. ,
High Risk of Sensitization After Failed Islet Transplantation, American Journal of Transplantation, vol.174, issue.10, pp.2311-2317, 2007. ,
DOI : 10.1016/j.trim.2005.01.001
Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies, Diabetes Care, vol.32, pp.1817-1819, 2009. ,
Autoantibody Response to Islet Transplantation in Type 1 Diabetes, Diabetes, vol.50, issue.11, pp.50-2464, 2001. ,
DOI : 10.2337/diabetes.50.11.2464
Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation, Experimental and Clinical Endocrinology & Diabetes, vol.108, issue.5, pp.328-333, 2000. ,
DOI : 10.1055/s-2000-8125
Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts, Transplantation, pp.85-256, 2008. ,
Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation, Clin. Exp. Immunol, pp.156-141, 2009. ,
Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells, J. Clin. Invest, vol.118, pp.1806-1814, 2008. ,
Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects, Clin. Exp. Immunol, pp.169-190, 2012. ,
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1, Diabetes Care, pp.28-1068, 2005. ,
Pathogenic and Regulatory T Cells in Type 1 Diabetes: Losing Self-Control, Restoring It, and How to Take the Temperature, Current Diabetes Reports, vol.60, issue.5, pp.11-426, 2011. ,
DOI : 10.1007/s11892-011-0209-8
Naturally arising human CD4 T cells that recognize islet autoantigens and secrete IL-10 regulate pro-inflammatory T cell responses via linked suppression, Diabetes, pp.59-1451, 2010. ,
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients, J. Clin. Invest, vol.121, pp.442-445, 2011. ,
MRI as a tool to monitor islet transplantation, Nature Reviews Endocrinology, vol.3, issue.8, pp.444-452, 2009. ,
DOI : 10.1038/nrendo.2009.130